[Chemotherapy of testicular cancer].

Der Urologe. Ausg. A
S KregeH Rübben

Abstract

Platinum-based polychemotherapy has increased the cure rate in testicular cancer dramatically: at first, chemotherapy was mainly used in advanced disease. Recently it has also become common in low-stage disease, though other therapeutic options are equivalent. Risk factors might help to find the right decision. The success of treatment in patients with metastatic disease results from the combination of chemotherapy and secondary surgery. High-dose chemotherapy for patients with poor prognosis or recurrent disease is being evaluated in clinical trials. Concerning the success in these stages prognostic factors are of special importance. Patients with advanced-stage nonseminoma need residual tumor resection after chemotherapy if no complete remission could be achieved. The therapist should be aware of the indication for and schedule of chemotherapy, its side effects, and supportive care.

References

Jun 4, 1987·The New England Journal of Medicine·S D WilliamsP J Loehrer
Sep 1, 1993·International Journal of Radiation Oncology, Biology, Physics·P R WardeA J Munro
Apr 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F BajorinP Sogani
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J PontW Höltl
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M H CullenR Jakes
Jan 1, 1997·Clinical Oncology : a Journal of the Royal College of Radiologists·G M Mead, S P Stenning
Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C BokemeyerC Nichols
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·M BambergM Flink
May 26, 2001·World Journal of Urology·J BeyerC Bokemeyer
Jun 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BeyerW Siegert
Nov 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Padraig WardeHans von der Maase
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AlbersUNKNOWN German Testicular Cancer Study Group
Nov 5, 1960·JAMA : the Journal of the American Medical Association·M C LIH GRABSTALD
Aug 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H J SchmollUNKNOWN European Germ Cell Cancer Consensus Group
Jun 2, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-L PicoUNKNOWN European Group for Blood and Marrow Transplantation (EBMT)
Jul 26, 2005·Lancet·R T D OliverUNKNOWN MRC TE19 collaborators and the EORTC 30982 collaborators
Oct 29, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S KregeUNKNOWN German Testicular Cancer Study Group (GTCSG)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Anticancer Therapy
Shiva DindyalPrasanna Sooriakumaran
The Oncologist
Maurie Markman, M A Bookman
International Journal of Urology : Official Journal of the Japanese Urological Association
Yoshiyuki KakehiOsamu Ogawa
© 2022 Meta ULC. All rights reserved